The Valley Desk

Clinical trial reportJournal of the American Heart AssociationPublished

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Lankenau Institute for Medical Research, Philadelphia VA Medical Center, with Main Line Health, Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the American Heart Association
Published
Subject terms
Humans; Atrial Fibrillation; Eicosapentaenoic Acid; Treatment Outcome; Risk Factors; Stroke; Eicosapentaenoic acid; Bleeding; Prevention; Atrial fibrillation; Icosapent Ethyl
PubMed ID
36802845
PubMed Central ID
PMC10111466
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal